Profil Financier
Mori Arkin occupe actuellement le rang #2551 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $1.6 B (-$427 sur 24h).
Mori Arkin got his start in business in 1972 helping his father run a small Israeli pharmaceutical distribution company.
The Arkins eventually moved into generic drug manufacturing, founding Agis Industries.
In 2004, they sold Agis to U.S. pharmaceutical company Perrigo for $818 million in cash and stock.
Still bullish on healthcare, he oversaw a January 2018 public offering on Nasdaq of Sol-Gel Technologies, a dermatology company. He owns over 62%.
His two sons are involved in the family business; his daughter is serving in the Israel Defense Forses.
Arkin is an art history buff and enjoys composing music as a hobby.